Structure, function, and genetics of lipoprotein (a)

K Schmidt, A Noureen, F Kronenberg… - Journal of lipid …, 2016 - ASBMB
Lipoprotein (a)[Lp (a)] has attracted the interest of researchers and physicians due to its
intriguing properties, including an intragenic multiallelic copy number variation in the LPA …

[HTML][HTML] Lipoprotein (a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality

Emerging Risk Factors Collaboration - JAMA: the journal of the …, 2009 - ncbi.nlm.nih.gov
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular
Mortality - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

Lipoprotein (a): resurrected by genetics

F Kronenberg, G Utermann - Journal of internal medicine, 2013 - Wiley Online Library
Plasma lipoprotein (a)[L p (a)] is a quantitative genetic trait with a very broad and skewed
distribution, which is largely controlled by genetic variants at the LPA locus on chromosome …

Genetic variants associated with Lp (a) lipoprotein level and coronary disease

R Clarke, JF Peden, JC Hopewell… - … England Journal of …, 2009 - Mass Medical Soc
Background An increased level of Lp (a) lipoprotein has been identified as a risk factor for
coronary artery disease that is highly heritable. The genetic determinants of the Lp (a) …

Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology

BG Nordestgaard, A Langsted - Journal of lipid research, 2016 - ASBMB
Human epidemiologic and genetic evidence using the Mendelian randomization approach
in large-scale studies now strongly supports that elevated lipoprotein (a)[Lp (a)] is a causal …

Prioritizing the role of major lipoproteins and subfractions as risk factors for peripheral artery disease

MG Levin, V Zuber, VM Walker, D Klarin, J Lynch… - Circulation, 2021 - Am Heart Assoc
Background: Lipoprotein-related traits have been consistently identified as risk factors for
atherosclerotic cardiovascular disease, largely on the basis of studies of coronary artery …

LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins

WQ Wei, X Li, Q Feng, M Kubo, IJ Kullo, PL Peissig… - Circulation, 2018 - Am Heart Assoc
Background: Coronary heart disease (CHD) is a leading cause of death globally. Although
therapy with statins decreases circulating levels of low-density lipoprotein cholesterol and …

Assessment of apolipoprotein (a) isoform size using phenotypic and genotypic methods

F Fogacci, V Di Micoli, A Avagimyan… - International Journal of …, 2023 - mdpi.com
Apolipoprotein (a)(apo (a)) is the protein component that defines lipoprotein (a)(Lp (a))
particles and is encoded by the LPA gene. The apo (a) is extremely heterogeneous in size …

Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis

LE Akioyamen, J Genest, A Chu, H Inibhunu… - Journal of clinical …, 2019 - Elsevier
Background Current data from individual studies present conflicting evidence about the
relationship between risk factors and cardiovascular disease (CVD) in heterozygous familial …

A Common LPA Null Allele Associates With Lower Lipoprotein(a) Levels and Coronary Artery Disease Risk

T Kyriakou, U Seedorf, A Goel… - … , and vascular biology, 2014 - Am Heart Assoc
Objective—Increased levels of lipoprotein (a) are a highly heritable risk factor for coronary
artery disease (CAD). The genetic determinants of lipoprotein (a) levels are mainly because …